phase i study of neihulizumab in patients with sr-agvhd or tr-agvhd
Published 1 year ago • 68 plays • Length 4:38Download video MP4
Download video MP3
Similar videos
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
1:04
phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
-
2:04
phase i/ii study of a novel bet inhibitor, bms-986158, alone & with ruxolitinib or fedratinib in mf
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
2:15
a phase i study investigating ruxolitinib and abemaciclib for primary or secondary myelofibrosis
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
3:18
a phase i study of jbh492, an anti-ccr7 antibody-drug conjugate, in lymphoid malignancies
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
3:46
overview of a phase i study of ono/gs-4059 in relapsed and refractory mature b-cell malignancies
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials